Hansenula polymorpha expressed heat shock protein gp96 exerts potent T cell activation activity as an adjuvant

Journal of Biotechnology

Volumn 151, Issue 4, 2011, Pages 343-349

  Li, Yang ^a   Song, Haolei ^a   Li, Jin ^b   Wang, Yanzhong ^a   Yan, Xiaoli ^a   Zhao, Bao ^a   Zhang, Xiaojun ^a   Wang, Saifeng ^a   Chen, Lizhao ^a   Qiu, Bingsheng ^a   Meng, Songdong ^a  

^a INSTITUTE OF MICROBIOLOGY   (China)

^b Beijing Tiantan Biological Products Co Ltd   (China)

Author keywords

Expression; Hansenula polymorpha; HBV; Peptide binding

Indexed keywords

CELL DENSITY; EFFICIENT METHOD; EXPRESSION; FED-BATCH CULTIVATION; HANSENULA POLYMORPHA; HBV; HEAT SHOCK PROTEIN; HIGH-LEVEL PRODUCTION; HIGH-ORDER STRUCTURE; IN-VITRO; INFECTIOUS DISEASE; INTRINSIC BINDING; PEPTIDE BINDING; RECOMBINANT PROTEIN; RECOMBINANT PROTEIN PRODUCTIONS; T CELL ACTIVATION; T-CELL RESPONSE;

ENZYMATIC HYDROLYSIS; ESCHERICHIA COLI; PEPTIDES;

DISEASES;

FREUND ADJUVANT; GLYCOPROTEIN GP 96; HEPATITIS B CORE ANTIGEN; IMMUNOLOGICAL ADJUVANT; PHENYLALANYLLEUCYLPROLYLSERYLASPARTYLPHENYLALANYLPHENYLALANYLPROLYLSERYLVALINE; RECOMBINANT PROTEIN; SERYLTYROSYLVALYLASPARAGINYLTHREONYLASPARAGINYLMETHIONYLGLYCYLLEUCINE; STARCH; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CELL DENSITY; CLONE; CONTROLLED STUDY; ESCHERICHIA COLI; FEMALE; GENE VECTOR; HEPATITIS B VIRUS; HYDROLYSIS; IMMUNE RESPONSE; IMMUNIZATION; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PICHIA ANGUSTA; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; SELF CONCEPT; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIGENS, NEOPLASM; HEAT-SHOCK PROTEINS; HUMANS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; PICHIA; RECOMBINANT PROTEINS; T-LYMPHOCYTES; VACCINES;

ESCHERICHIA COLI; HEPATITIS B VIRUS; MUS; PICHIA ANGUSTA;

EID: 79951555513     PISSN: 01681656     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbiotec.2010.12.006     Document Type: Article

References (33)

1. Bolhassani A., Rafati S. Heat-shock proteins as powerful weapons in vaccine development. Expert Rev. Vaccines 2008, 7:1185-1199.
2. Bolhassani A., Zahedifard F., Taghikhani M., Rafati S. Enhanced immunogenicity of HPV16E7 accompanied by Gp96 as an adjuvant in two vaccination strategies. Vaccine 2008, 26:3362-3370.
3. Ding F.X., Wang F., Lu Y.M., Li K., Wang K.H., He X.W., Sun S.H. Multiepitope peptide-loaded virus-like particles as a vaccine against hepatitis B virus-related hepatocellular carcinoma. Hepatology 2009, 49:1492-1502.
4. + T cell effector function. J. Immunol. 2004, 172:6087-6092.
5. Faber K.N., Haima P., Harder W., Veenhuis M., Ab G. Highly-efficient electrotransformation of the yeast Hansenula polymorpha. Curr. Genet. 1994, 25:305-310.
6. Fan H., Kashi R.S., Middaugh C.R. Conformational lability of two molecular chaperones Hsc70 and gp96: effects of pH and temperature. Arch. Biochem. Biophys. 2006, 447:34-45.
7. Gellissen G. Heterologous protein production in methylotrophic yeasts. Appl. Microbiol. Biotechnol. 2000, 54:741-750.
8. Gidalevitz T., Biswas C., Ding H., Schneidman-Duhovny D., Wolfson H.J., Stevens F., Radford S., Argon Y. Identification of the N-terminal peptide binding site of glucose-regulated protein 94. J. Biol. Chem. 2004, 279:16543-16552.
9. Gietl C., Faber K.N., van der Klei I.J., Veenhuis M. Mutational analysis of the N-terminal topogenic signal of watermelon glyoxysomal malate dehydrogenase using the heterologous host Hansenula polymorpha. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:3151-3155.
10. Gong X., Gai W., Xu J., Zhou W., Tien P. Glycoprotein 96-mediated presentation of human immunodeficiency virus type 1 (HIV-1)-specific human leukocyte antigen class I-restricted peptide and humoral immune responses to HIV-1 p24. Clin. Vaccine Immunol. 2009, 16:1595-1600.
11. Hollenberg C.P., Gellissen G. Production of recombinant proteins by methylotrophic yeasts. Curr. Opin. Biotechnol. 1997, 8:554-560.
12. Kropp L.E., Garg M., Binder R.J. Ovalbumin-derived precursor peptides are transferred sequentially from gp96 and calreticulin to MHC class I in the endoplasmic reticulum. J. Immunol. 2010, 184:5619-5627.
13. Li H., Zhou M., Han J., Zhu X., Dong T., Gao G.F., Tien P. Generation of murine CTL by a hepatitis B virus-specific peptide and evaluation of the adjuvant effect of heat shock protein glycoprotein 96 and its terminal fragments. J. Immunol. 2005, 174:195-204.
14. Linderoth N.A., Simon M.N., Rodionova N.A., Cadene M., Laws W.R., Chait B.T., Sastry S. Biophysical analysis of the endoplasmic reticulum-resident chaperone/heat shock protein gp96/GRP94 and its complex with peptide antigen. Biochemistry 2001, 40:1483-1495.
15. Liu Z., Li X., Qiu L., Zhang X., Chen L., Cao S., Wang F., Meng S. Treg suppress CTL responses upon immunization with HSP gp96. Eur. J. Immunol. 2009, 39:3110-3120.
16. Mayer A.F., Hellmuth K., Schlieker H., Lopez-Ulibarri R., Oertel S., Dahlems U., Strasser A.W., van Loon A.P. An expression system matures: a highly efficient and cost-effective process for phytase production by recombinant strains of Hansenula polymorpha. Biotechnol. Bioeng. 1999, 63:373-381.
17. McGettrick A.F., O'Neill L.A. Localisation and trafficking of Toll-like receptors: an important mode of regulation. Curr. Opin. Immunol. 2010, 22:20-27.
18. Meng S.D., Gao T., Gao G.F., Tien P. HBV-specific peptide associated with heat-shock protein gp96. Lancet 2001, 357:528-529.
19. Meng S.D., Song J., Rao Z., Tien P., Gao G.F. Three-step purification of gp96 from human liver tumor tissues suitable for isolation of gp96-bound peptides. J. Immunol. Methods 2002, 264:29-35.
20. + T cells. Cell Stress Chaperones 2006, 11:364-378.
21. Pakravan N., Soleimanjahi H., Hassan Z.M. GP96 C-terminal improves Her2/neu DNA vaccine. J. Gene Med. 2010, 12:345-353.
22. Qian W., Song H., Liu Y., Zhang C., Niu Z., Wang H., Qiu B. Improved gene disruption method and Cre-loxP mutant system for multiple gene disruptions in Hansenula polymorpha. J. Microbiol. Methods 2009, 79:253-259.
23. Robert J., Ramanayake T., Maniero G.D., Morales H., Chida A.S. Phylogenetic conservation of glycoprotein 96 ability to interact with CD91 and facilitate antigen cross-presentation. J. Immunol. 2008, 180:3176-3182.
24. Schreiber T.H., Deyev V.V., Rosenblatt J.D., Podack E.R. Tumor-induced suppression of CTL expansion and subjugation by gp96-Ig vaccination. Cancer Res. 2009, 69:2026-2033.
25. SenGupta D., Norris P.J., Suscovich T.J., Hassan-Zahraee M., Moffett H.F., Trocha A., Draenert R., Goulder P.J., Binder R.J., Levey D.L., Walker B.D., Srivastava P.K., Brander C. Heat shock protein-mediated cross-presentation of exogenous HIV antigen on HLA class I and class II. J. Immunol. 2004, 173:1987-1993.
26. Song H., Li Y., Fang W., Geng Y., Wang X., Wang M., Qiu B. Development of a set of expression vectors in Hansenula polymorpha. Biotechnol. Lett. 2003, 25:1999-2006.
27. Srivastava P. Roles of heat-shock proteins in innate and adaptive immunity. Nat. Rev. Immunol. 2002, 2:185-194.
28. Thorne M.E., McQuade K.L. Heat-induced oligomerization of gp96 occurs via a site distinct from substrate binding and is regulated by ATP. Biochem. Biophys. Res. Commun. 2004, 323:1163-1171.
29. van Dijk R., Faber K.N., Kiel J.A., Veenhuis M., van der Klei I. The methylotrophic yeast Hansenula polymorpha: a versatile cell factory. Enzyme Microb. Technol. 2000, 26:793-800.
30. Vogen S., Gidalevitz T., Biswas C., Simen B.B., Stein E., Gulmen F., Argon Y. Radicicol-sensitive peptide binding to the N-terminal portion of GRP94. J. Biol. Chem. 2002, 277:40742-40750.
31. Warger T., Hilf N., Rechtsteiner G., Haselmayer P., Carrick D.M., Jonuleit H., von Landenberg P., Rammensee H.G., Nicchitta C.V., Radsak M.P., Schild H. Interaction of TLR2 and TLR4 ligands with the N-terminal domain of Gp96 amplifies innate and adaptive immune responses. J. Biol. Chem. 2006, 281:22545-22553.
32. Wood C.G., Mulders P. Vitespen: a preclinical and clinical review. Future Oncol. 2009, 5:763-774.
33. Yang Y., Liu B., Dai J., Srivastava P.K., Zammit D.J., Lefrancois L., Li Z. Heat shock protein gp96 is a master chaperone for toll-like receptors and is important in the innate function of macrophages. Immunity 2007, 26:215-226.